Dr. Gibson, inventor of Gibson Assembly®, joined Synthetic Genomics in February of 2011 after spending more than six years at the J. Craig Venter Institute (JCVI) where he co-led the team that constructed the first synthetic bacterial genome in 2008 and the first synthetic cell in 2010. At Synthetic Genomics, Dr. Gibson spearheaded efforts to develop a rapid approach for producing accurate influenza genes used in synthetic flu vaccine production in 2013 and synthesized the first minimal cell in 2016 together with JCVI scientists. Dr. Gibson co-founded SGI-DNA in 2013 and, with his team of scientists, formed the foundational technology that drives the BioXp and the Digital to Biological Converter (DBC) and continue to develop new, cutting edge tools for whole genome design, synthesis and assembly, and activation.
Dr. Gibson earned his Ph.D. in Molecular Biology from the University of Southern California. Before earning his Ph.D., he earned his Bachelor’s degree in Biological Sciences from the State University of New York at Buffalo.